• Study reports abnormally high VTE and high bleed risk in critically ill COVID-19 patients and calls for more effective prevention strategies.
  • Clinicians at NHS hospitals are supporting the care of COVID-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
Learn more Contact us

OnPulse Technology

The revolutionary neuromuscular electrostimulation technology developed by Firstkind

Find out more

geko™ product

Hospital Applications Device

Find out more

Partner with us

What can the geko™ do for my patients?

News

The Sunday Times article – Clot-busters to tackle coronavirus patients’ blood problems

News

Changing clinical practice: The burden of post-stroke VTE prevention

News

Rachel Fallon, CTO Sky Medical Technology Ltd, speaks to Women of Wearables (WoW) about the challenges for women in STEM (Science, technology , engineering and Maths)